Prospective population-based study of rsv-related intermediate care and intensive care unit admissions in Switzerland over a 4-year period (2001-2005)

Infection

Volumn 37, Issue 2, 2009, Pages 109-116

  Berger, T M ^a   Aebi, C ^b   Duppenthaler, A ^b   Stocker, M ^a  

^a CHILDREN S HOSPITAL   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

PALIVIZUMAB;

ARTICLE; ASSISTED VENTILATION; CHILD; CONGENITAL HEART DISEASE; CONTROLLED STUDY; DISEASE SEVERITY; GESTATIONAL AGE; HIGH RISK INFANT; HOSPITAL; HOSPITAL ADMISSION; HUMAN; INFANT; INTENSIVE CARE UNIT; LENGTH OF STAY; LUNG DYSPLASIA; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; POPULATION RESEARCH; PREMATURITY; PRESCHOOL CHILD; PROSPECTIVE STUDY; QUESTIONNAIRE; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RISK FACTOR; SWITZERLAND; VIRUS INFECTION;

ANTIBODIES, MONOCLONAL; BRONCHOPULMONARY DYSPLASIA; CHILD, PRESCHOOL; HEART DISEASES; HOSPITAL UNITS; HOSPITALIZATION; HUMANS; INFANT; INFANT, NEWBORN; INFANT, PREMATURE; INTENSIVE CARE UNITS; PROSPECTIVE STUDIES; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUSES; RISK FACTORS; STATISTICS, NONPARAMETRIC; SWITZERLAND;

EID: 65149100246     PISSN: 03008126     EISSN: None     Source Type: Journal    
DOI: 10.1007/s15010-008-8130-z     Document Type: Article

References (46)

1. C.P. Black 2003 Systematic review of the biology and medical management of respiratory syncytial virus infection Respir Care 48 209 31
2. Everard ML, Bara A, Kurian M, Elliott TM, Ducharme F, Mayowe V: Anticholinergic drugs for wheeze in children under the age of two years. Cochrane Datab Syst Rev 2005; CD001279.
3. Spurling GK, Fonseka K, Doust J, Del Mar C: Antibiotics for bronchiolitis in children. Cochrane Database Syst Rev 2007; CD005189.
4. Perrotta C, Ortiz Z, Roque M: Chest physiotherapy for acute bronchiolitis in paediatric patients between 0 and 24 months old. Cochrane Database Syst Rev 2007; CD004873.
5. K. Ventre M. Haroon C. Davison 2006 Surfactant therapy for bronchiolitis in critically ill infants Cochrane Database Syst Rev 3 CD005150
6. A.M. Gadomski A.L. Bhasale 2006 Bronchodilators for bronchiolitis Cochrane Database Syst Rev 3 CD001266
7. Blom D, Ermers M, Bont L, van Aalderen WM, van Woensel JB: Inhaled corticosteroids during acute bronchiolitis in the prevention of post-bronchiolitic wheezing. Cochrane Database Syst Rev 2007; CD004881.
8. Patel H, Platt R, Lozano JM, Wang EE: Glucocorticoids for acute viral bronchiolitis in infants and young children. Cochrane Database Syst Rev 2004; CD004878.
9. Hartling L, Wiebe N, Russell K, Patel H, Klassen TP: Epinephrine for bronchiolitis. Cochrane Database Syst Rev 2004; CD003123.
10. D. Hodge P.A. Chetcuti 2000 RSV: management of the acute episode Paediatr Respir Rev 1 215 220
11. Reduction of respiratory syncytial virus hospitalization among premature infants and infants with bronchopulmonary dysplasia using respiratory syncytial virus immune globulin prophylaxis. The PREVENT Study Group. Pediatrics 1997; 99:93-99.
12. J.R. Groothuis E.A. Simoes M.J. Levin 1993 Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. The Respiratory Syncytial Virus Immune Globulin Study Group N Engl J Med 329 1524 1530
13. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. The IMpact-RSV Study Group. Pediatrics 1998; 102: 531-537.
14. T.F. Feltes A.K. Cabalka H.C. Meissner 2003 Palivizumab prophylaxis reduces hospitalization due to respiratory syncytial virus in young children with hemodynamically significant congenital heart disease J Pediatr 143 532 540 (Pubitemid 37352516)
15. American Academy of Pediatrics Committee on Infectious DiseasesCommittee on FetusNewborn. 2003 Revised indications for the use of palivizumab and respiratory syncytial virus immune globulin intravenous for the prevention of respiratory syncytial virus infections Pediatrics 112 1442 1446 (Pubitemid 37523437)
16. National Advisory Committee on Immunization. 2003 Statement on the recommended use of monoclonal anti-RSV antibody (palivizumab) Can Commun Dis Rep 29 1 15
17. X. Carbonell Estrany J. Quero Jimenez 2000 Recommendations for the prevention of respiratory syncytial virus infections. Standards Committee of the Spanish Society of Neonatology. Board of Directors of the Spanish Society of Neonatology An Esp Pediatr 52 372 374
18. X. Carbonell-Estrany J. Quero Jimenez 2002 Guidelines for respiratory syncytial virus prophylaxis. An update An Esp Pediatr 56 334 336
19. A. Chantepie 2004 Use of palivizumab for the prevention of respiratory syncytial virus infections in children with congenital heart disease. Recommendations from the French Paediatric Cardiac Society Arch Pediatr 11 1402 1405 (Pubitemid 39446428)
20. J. Figueras Aloy J. Quero E. Domenech 2005 Recommendations for the prevention of respiratory syncytial virus infection An Pediatr (Barc) 63 357 362 (Pubitemid 41695929)
21. J. Forster 1999 Practice guideline by the German Society for Pediatric Infectious Diseases with respect to prevention of RSV infections through immunoglobulin administration Klin Padiatr 211 476 (Pubitemid 29535838)
22. L. Naver M. Eriksson U. Ewald A. Linde M. Lindroth J. Schollin 2004 Appropriate prophylaxis with restrictive palivizumab regimen in preterm children in Sweden Acta Paediatr 93 1470 1473 (Pubitemid 39457061)
23. R. Tulloh M. Marsh M. Blackburn 2003 Recommendations for the use of palivizumab as prophylaxis against respiratory syncytial virus in infants with congenital cardiac disease Cardiol Young 13 420 423 (Pubitemid 41630963)
24. C. Aebi C. Barrazone J. Günthardt 2004 Konsensus-Statement zur Prävention von Respiratory Syncytial Virus (RSV)-Infektionen mit dem humanisierten monoklonalen Antikörper Palivizumab (Synagis). Update 2004 Paediatrica 15 12 16
25. C. Aebi C. Barrazone J. Hammer C. Kind D. Nadal R.E. Pfister 2002 Update zum Konsensus-Statement zur Prävention von Respiratory Syncytial Virus (RSV)-Infektionen bei Säuglingen mit dem humanisierten monoklonalen Antikörper Palivizumab (Synagis) Paediatrica 13 58 60
26. A.H. Jobe E. Bancalari 2001 Bronchopulmonary dysplasia Am J Respir Crit Care Med 163 1723 1729 (Pubitemid 32578778)
27. A. Duppenthaler M. Gorgievski-Hrisoho U. Frey C. Aebi 2003 Two-year periodicity of respiratory syncytial virus epidemics in Switzerland Infection 31 75 80 (Pubitemid 36437719)
28. H.U. Bucher C.L. Fawer J. von Kaenel C. Kind A. Moessinger 1998 Intrauterine and postnatal transfer of high risk newborn infants. Swiss Society of Neonatology Schweiz Med Wochenschr 128 1646 1653
29. A. Duppenthaler R.A. Ammann M. Gorgievski-Hrisoho J.P. Pfammatter C. Aebi 2004 Low incidence of respiratory syncytial virus hospitalisations in haemodynamically significant congenital heart disease Arch Dis Child 89 961 965 (Pubitemid 39331390)
30. J. Henderson T.N. Hilliard A. Sherriff D. Stalker N. Al Shammari H.M. Thomas 2005 Hospitalization for RSV bronchiolitis before 12 months of age and subsequent asthma, atopy and wheeze: a longitudinal birth cohort study Pediatr Allergy Immunol 16 386 392 (Pubitemid 41207478)
31. K.G. Nicholson T. McNally M. Silverman P. Simons J.D. Stockton M.C. Zambon 2006 Rates of hospitalisation for influenza, respiratory syncytial virus and human metapneumovirus among infants and young children Vaccine 24 102 108 (Pubitemid 41721106)
32. A.G. Jansen E.A. Sanders A.W. Hoes A.M. van Loon E. Hak 2007 Influenza-and respiratory syncytial virus-associated mortality and hospitalisations Eur Respir J 30 1158 1166
33. L. Sangare M.P. Curtis S. Ahmad 2006 Hospitalization for respiratory syncytial virus among California infants: disparities related to race, insurance, and geography J Pediatr 149 373 377 (Pubitemid 44308426)
34. K. Purcell J. Fergie 2004 Driscoll Children's Hospital respiratory syncytial virus database: risk factors, treatment and hospital course in 3308 infants and young children, 1991 to 2002 Pediatr Infect Dis J 23 418 423 (Pubitemid 38621480)
35. D. Prais D. Danino T. Schonfeld J. Amir 2005 Impact of palivizumab on admission to the ICU for respiratory syncytial virus bronchiolitis: a national survey Chest 128 2765 2771 (Pubitemid 41507638)
36. A. Lopez Guinea J. Casado Flores M.A. Martin Sobrino 2007 Severe bronchiolitis. Epidemiology and clinical course of 284 patients An Pediatr (Barc) 67 116 122 (Pubitemid 47282222)
37. G.A. Rossi M.C. Medici M.C. Arcangeletti 2007 Risk factors for severe RSV-induced lower respiratory tract infection over four consecutive epidemics Eur J Pediatr 166 1267 1272 (Pubitemid 350029479)
38. R. Janssen L. Bont C.L. Siezen 2007 Genetic susceptibility to respiratory syncytial virus bronchiolitis is predominantly associated with innate immune genes J Infect Dis 196 826 834 (Pubitemid 47378931)
39. A. Simon R.A. Ammann A. Wilkesmann 2007 Respiratory syncytial virus infection in 406 hospitalized premature infants: results from a prospective German multicentre database Eur J Pediatr 166 1273 1283 (Pubitemid 350029480)
40. A. Duppenthaler M. Gorgievski-Hrisoho C. Aebi 2001 Regional impact of prophylaxis with the monoclonal antibody palivizumab on hospitalisations for respiratory syncytial virus in infants Swiss Med Wkly 131 146 151 (Pubitemid 32246499)
41. N.D. Embleton C. Harkensee M.C. McKean 2005 Palivizumab for preterm infants. Is it worth it? Arch Dis Child Fetal Neonatal Ed 90 F286 F289 (Pubitemid 40933387)
42. A. Meberg A.L. Bruu 2006 Respiratory syncytial virus infections in congenital heart defects - hospitalizations and costs Acta Paediatr 95 404 406 (Pubitemid 43739064)
43. C.A. Reeve J.S. Whitehall P.G. Buettner R. Norton D.M. Reeve F. Francis 2006 Cost-effectiveness of respiratory syncytial virus prophylaxis with palivizumab J Paediatr Child Health 42 253 258 (Pubitemid 43736361)
44. M.J. Nuijten W. Wittenberg M. Lebmeier 2007 Cost effectiveness of palivizumab for respiratory syncytial virus prophylaxis in high-risk children: a UK analysis Pharmacoeconomics 25 55 71 (Pubitemid 46072368)
45. M.K. Iwane K.M. Edwards P.G. Szilagyi 2004 Population-based surveillance for hospitalizations associated with respiratory syncytial virus, influenza virus, and parainfluenza viruses among young children Pediatrics 113 1758 1764 (Pubitemid 38697988)
46. Y.J. Kim M. Boeckh J.A. Englund 2007 Community respiratory virus infections in immunocompromised patients: hematopoietic stem cell and solid organ transplant recipients, and individuals with human immunodeficiency virus infection Semin Respir Crit Care Med 28 222 242 (Pubitemid 46676916)